Platelet interaction with the vessel wall

Handbook of Experimental Pharmacology

Volumn 210, Issue , 2012, Pages 87-110

  De Groot, Philip G ^a   Urbanus, Rolf T ^a   Roest, Mark ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Platelet activation; Platelet adhesion; Secondary hemostasis

Indexed keywords

CELL PROTEIN; PROTEIN GPIB ALPHA; THROMBIN RECEPTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; ADHESION RECEPTOR; MEMBRANE PROTEIN;

ARTICLE; BLOOD VESSEL WALL; HEMOSTASIS; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBUS; VASCULAR ENDOTHELIUM; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HUMANS; MEMBRANE GLYCOPROTEINS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 84867158928     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-29423-5_4     Document Type: Article

References (108)

1. Agbanyo FR, Sixma JJ, de Groot PG, Languino LR, Plow EF (1993) Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest 92:288-296
2. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD (2002) CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 8:247-252
3. Andrews RK, Gardiner EE, Shen Y, Whisstock JC, Berndt MC (2003) Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 35:1170-1174
4. Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F, Arnout J, Dewerchin M, Hoylaerts M, Herbert J, Collen D, Dahlback B, Carmeliet P (2001) Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 7:215-221
5. Baglia FA, Shrimpton CN, Lopez JA, Walsh PN (2003) The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane. J Biol Chem 278:21744-21750
6. Beumer S, Heijnen HF, IJsseldijk MJ, Orlando E, de Groot PG, Sixma JJ (1995) Platelet adhesion to fibronectin in flow: the importance of von Willebrand factor and glycoprotein Ib. Blood 86:3452-3460
7. Bradford HN, Pixley RA, Colman RW (2000) Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem 275: 22756-22763
8. Broos K, Feys HB, De Meyer SF, Vanhoorelbeke K, Deckmyn H (2011) Platelets at work in primary hemostasis. Blood Rev 25:155-167
9. Broze GJ Jr, Girard TJ, Novotny WF (1990) Regulation of coagulation by a multivalent Kunitztype inhibitor. Biochemistry 29:7539-7546
10. Camire RM, Pollak ES, Kaushansky K, Tracy PB (1998) Secretable human platelet-derived factor V originates from the plasma pool. Blood 92:3035-3041
11. Cattaneo M (2011) Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphate. Thromb Haemost 105(Suppl 1):S67-S74
12. Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML (2000) Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol 20:E101-E106
13. Chauhan AK, Walsh MT, Zhu G, Ginsburg D, Wagner DD, Motto DG (2008) The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis. Blood 111:3452-3457
14. Chen H, Locke D, Liu Y, Liu C, Kahn ML (2002) The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem 277:3011-3019
15. Clauser S, Bachelot-Lozat C, Fontana P, Gaussem P, Remones V, Aiach M, Borgel D (2006) Physiological plasma Gas6 levels do not influence platelet aggregation. Arterioscler Thromb Vasc Biol 26:e22
16. Clemetson KJ (2007) A short history of platelet glycoprotein Ib complex. Thromb Haemost 98:63-68
17. Cohen I, Gerrard JM, White JG (1982) Ultrastructure of clots during isometric contraction. J Cell Biol 93:775-787
18. Cosemans JM, Van Kruchten R, Olieslagers S, Schurgers LJ, Verheyen FK, Munnix IC, Waltenberger J, Angelillo-Scherrer A, Hoylaerts MF, Carmeliet P, Heemskerk JW (2010) Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization. J Thromb Haemost 8:1797-1808
19. Davies MJ, Bland JM, Hangartner JR, Angelini A, Thomas AC (1989) Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death. Eur Heart J 10:203-208
20. de Groot PG, Sixma JJ (2002) Platelet adhesion. In: Gresele P, Page CP, Fuster V, Vermylen J (eds) Platelets in thrombotic and non thrombotic disorders: pathophysiology, pharmacology and therapeutics. Cambridge University Press, Cambridge
21. Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, Hynes RO, Wagner DD (1998) A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 95:9524-9529
22. Dong JF (2005) Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J Thromb Haemost 3:1710-1716
23. Du X (2007) Signaling and regulation of the platelet glycoprotein Ib-IX-V complex. Curr Opin Hematol 14:262-269
24. Duckers C, Simioni P, Spiezia L, Radu C, Dabrilli P, Gavasso S, Rosing J, Castoldi E (2010) Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood 115:879-886
25. Esmon CT (2003) The protein C pathway. Chest 124:26S-32S
26. French JE, Macfarlane RG, Sanders AG (1964) The structure of haemostatic plugs and experimental thrombi in small arteries. Br J Exp Pathol 45:467-474
27. Frenette PS, Johnson RC, Hynes RO, Wagner DD (1995) Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 92:7450-7454
28. Furie B, Furie BC (2005) Thrombus formation in vivo. J Clin Invest 115:3355-3362
29. Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11:123-134
30. Gayle RB 3rd, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, Brasel K, Price V, Drosopoulos JH, Islam N, Alyonycheva TN, Broekman MJ, Marcus AJ (1998) Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest 101:1851-1859
31. Gruner S, Prostredna M, Schulte V, Krieg T, Eckes B, Brakebusch C, Nieswandt B (2003) Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood 102:4021-4027
32. Hackeng TM, Sere KM, Tans G, Rosing J (2006) Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci USA 103:3106-3111
33. Hantgan RR, Endenburg SC, Cavero I, Marguerie G, Uzan A, Sixma JJ, de Groot PG (1992) Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by Arg-Gly-Asp and fibrinogen gamma-chain carboxy terminal peptides. Thromb Haemost 68:694-700
34. Hindriks G, Ijsseldijk MJ, Sonnenberg A, Sixma JJ, de Groot PG (1992) Platelet adhesion to laminin: role of Ca2+ and Mg2+ ions, shear rate, and platelet membrane glycoproteins. Blood 79:928-935
35. Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, Sixma JJ, Gros P (2002) Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 297:1176-1179
36. Jung SM, Moroi M (2008) Platelet glycoprotein VI. Adv Exp Med Biol 640:53-63
37. Jurk K, Clemetson KJ, de Groot PG, Brodde MF, Steiner M, Savion N, Varon D, Sixma JJ, Van Aken H, Kehrel BE (2003) Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J 17:1490-1492
38. Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J (2003) The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 102:1701-1707
39. Kawamoto Y, KaibaraM(1990) Procoagulant activity of collagen. Effect of difference in type and structure of collagen. Biochim Biophys Acta 1035:361-368
40. Kim J, Zhang CZ, Zhang X, Springer TA (2010) A mechanically stabilized receptor-ligand flexbond important in the vasculature. Nature 466:992-995
41. Kiyoi T, Tomiyama Y, Honda S, Tadokoro S, Arai M, Kashiwagi H, Kosugi S, Kato H, Kurata Y, Matsuzawa Y (2003) A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects. Blood 101:3485-3491
42. Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff DJ, Ruggeri ZM (2006) Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost 4:2014-2021
43. Lankhof H, van Hoeij M, Schiphorst ME, Bracke M, Wu YP, Ijsseldijk MJ, Vink T, de Groot PG, Sixma JJ (1996) A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost 75:950-958
44. Leger AJ, Covic L, Kuliopulos A (2006) Protease-activated receptors in cardiovascular diseases. Circulation 114:1070-1077
45. Lisman T, Raynal N, Groeneveld D, Maddox B, Peachey AR, Huizinga EG, de Groot PG, Farndale RW (2006) A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides. Blood 108:3753-3756
46. Lubnitzky S (1885) Die Zusammensetzung des Thrombus in Arterienwunden in den ersten funf Tagen. Naunyn-Schmeidebergs Arch Pharmacol 19:185
47. Luo SZ, Mo X, Afshar-Kharghan V, Srinivasan S, Lopez JA, Li R (2007) Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet. Blood 109:603-609
48. Maroney SA, Haberichter SL, Friese P, Collins ML, Ferrel JP, Dale GL, Mast AE (2007) Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood 109:1931-1937
49. Maynard DM, Heijnen HF, Gahl WA, Gunay-AygunM(2010) The alpha-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost 8:1786-1796
50. Muller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, Spronk HM, Schmidbauer S, Gahl WA, Morrissey JH, Renne T (2009) Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139:1143-1156
51. Nachman RL, Rafii S (2008) Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 359:1261-1270
52. Nesbitt WS, Westein E, Tovar-Lopez FJ, Tolouei E, Mitchell A, Fu J, Carberry J, Fouras A, Jackson SP (2009) A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 15:665-673
53. Newman PJ, Newman DK (2003) Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 23:953-964
54. Nieswandt B, Varga-Szabo D, Elvers M (2009) Integrins in platelet activation. J Thromb Haemost 7(Suppl 1):206-209
55. Nieswandt B, Pleines I, Bender M (2011) Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost 9(Suppl 1):92-104
56. Niewiarowski S, Bankowski E, Fiedoruk T (1964) Adsorption of Hageman factor (Factor XII) on collagen. Experientia 20:367-368
57. Noe L, Peeters K, Izzi B, Van Geet C, Freson K (2010) Regulators of platelet cAMP levels: clinical and therapeutic implications. Curr Med Chem 17:2897-2905
58. Nurden AT (2011) Platelets, inflammation and tissue regeneration. Thromb Haemost 105(Suppl 1):S13-S33
59. Nurden A, Nurden P (2011) Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost 9(Suppl 1):76-91
60. Offermanns S (2006) Activation of platelet function through G protein-coupled receptors. Circ Res 99:1293-1304
61. Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526
62. Prevost N, Woulfe DS, Tognolini M, Tanaka T, Jian W, Fortna RR, Jiang H, Brass LF (2004) Signaling by ephrinB1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation of ephrinB1. Blood 103:1348-1355
63. Prevost N, Woulfe DS, Jiang H, Stalker TJ, Marchese P, Ruggeri ZM, Brass LF (2005) Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci USA 102:9820-9825
64. Pries AR, Secomb TW, Jacobs H, Sperandio M, Osterloh K, Gaehtgens P (1997) Microvascular blood flow resistance: role of endothelial surface layer. Am J Physiol 273:H2272-H2279
65. Pugh N, Simpson AM, Smethurst PA, de Groot PG, Raynal N, Farndale RW (2010) Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood 115:5069-5079
66. Ramesh S, Morrell CN, Tarango C, Thomas GD, Yuhanna IS, Girardi G, Herz J, Urbanus RT, de Groot PG, Thorpe PE, Salmon JE, Shaul PW, Mineo C (2011) Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta2GPI and apoER2. J Clin Invest 121:120-131
67. Reitsma S, Oude Egbrink MG, Heijnen VV, Megens RT, Engels W, Vink H, Slaaf DW, van Zandvoort MA (2011) Endothelial glycocalyx thickness and platelet-vessel wall interactions during atherogenesis. Thromb Haemost 106(5):939-46. doi:10.1160/TH11-02-0133
68. Renne T, Pozgajova M, Gruner S, Schuh K, Pauer HU, Burfeind P, Gailani D, Nieswandt B (2005) Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 202:271-281
69. Rosen ED, Gailani D, Castellino FJ (2002) FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb Haemost 87:774-776
70. Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 295:369-377
71. Ruggeri ZM (2000) Old concepts and new developments in the study of platelet aggregation. J Clin Invest 105:699-701
72. Ruiz FA, Lea CR, Oldfield E, Docampo R (2004) Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem 279:44250-44257
73. Sabrkhany S, Griffioen AW, Oude Egbrink MG (2011) The role of blood platelets in tumor angiogenesis. Biochim Biophys Acta 1815:189-196
74. Sadler JE (2005) von Willebrand factor: two sides of a coin. J Thromb Haemost 3:1702-1709
75. Sakariassen KS, Bolhuis PA, Sixma JJ (1979) Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature 279:636-638
76. Santoro SA (1986) Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 46:913-920
77. Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289-297
78. Savage B, Almus-Jacobs F, Ruggeri ZM (1998) Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 94:657-666
79. Savage B, Sixma JJ, Ruggeri ZM (2002) Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Natl Acad Sci USA 99:425-430
80. Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264-274
81. Sixma JJ, van den Berg A (1984) The haemostatic plug in haemophilia A: a morphological study of haemostatic plug formation in bleeding time skin wounds of patients with severe haemophilia A. Br J Haematol 58:741-753
82. Sixma JJ, Sakariassen KS, Beeser-Visser NH, Ottenhof-Rovers M, Bolhuis PA (1984) Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition. Blood 63:128-139
83. Smith SA, Morrissey JH (2008) Polyphosphate enhances fibrin clot structure. Blood 112:2810-2816
84. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH (2006) Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci USA 103:903-908
85. Smith SA, Choi SH, Davis-Harrison R, Huyck J, Boettcher J, Rienstra CM, Morrissey JH (2010) Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood 116:4353-4359
86. Stalker TJ, Wu J, Morgans A, Traxler EA, Wang L, Chatterjee MS, Lee D, Quertermous T, Hall RA, Hammer DA, Diamond SL, Brass LF (2009) Endothelial cell specific adhesion molecule (ESAM) localizes to platelet-platelet contacts and regulates thrombus formation in vivo. J Thromb Haemost 7:1886-1896
87. Stegner D, Nieswandt B (2011) Platelet receptor signaling in thrombus formation. J Mol Med (Berl) 89:109-121
88. Stitham J, Arehart EJ, Gleim SR, Douville KL, Hwa J (2007) Human prostacyclin receptor structure and function from naturally-occurring and synthetic mutations. Prostaglandins Other Lipid Mediat 82:95-108
89. Stitham J, Arehart E, Elderon L, Gleim SR, Douville K, Kasza Z, Fetalvero K, MacKenzie T, Robb J, Martin KA, Hwa J (2011) Comprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction. J Biol Chem 286:7060-7069
90. Storey RF (2011) New P2Y inhibitors. Heart 97:1262-1267
91. Suzuki J, Umeda M, Sims PJ, Nagata S (2010) Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468:834-838
92. Thiery JP, Bessis M (1956) Mechanism of platelet genesis; in vitro study by cinemicrophotography. Rev Hematol 11:162-174
93. Tucker EI, Marzec UM, White TC, Hurst S, Rugonyi S, McCarty OJ, Gailani D, Gruber A, Hanson SR (2009) Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 113:936-944
94. Ulrichts H, Udvardy M, Lenting PJ, Pareyn I, Vandeputte N, Vanhoorelbeke K, Deckmyn H (2006) Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J Biol Chem 281:4699-4707
95. van Hinsbergh VW (2012) Endothelium-role in regulation of coagulation and inflammation. Semin Immunopathol 34(1):93-106. doi:10.1007/s00281-011-0285-5
96. Wang X, Smith PL, Hsu MY, Gailani D, Schumacher WA, Ogletree ML, Seiffert DA (2006) Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice. J Thromb Haemost 4:1982-1988
97. Ward CM, Kestin AS, Newman PJ (2000) A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen. Blood 96:161-169
98. Ware J, Russell S, Ruggeri ZM (2000) Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci USA 97:2803-2808
99. Watson SP, Herbert JM, Pollitt AY (2010) GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 8:1456-1467
100. Weiss HJ, Turitto VT, Baumgartner HR (1991) Further evidence that glycoprotein IIb-IIIa mediates platelet spreading on subendothelium. Thromb Haemost 65:202-205
101. White JG (2002) Morphology and ultrastructure of platelets. In: Gresele P, Page CP, Fuster V, Vermylen J (eds) Platelets in thrombotic and non-thrombotic disorders: pathophysiology, pharmacology and therapeutics. Cambridge University Press, Cambridge
102. White-Adams TC, Berny MA, Tucker EI, Gertz JM, Gailani D, Urbanus RT, de Groot PG, Gruber A, McCarty OJ (2009) Identification of coagulation factor XI as a ligand for platelet apolipoprotein. E receptor 2 (ApoER2). Arterioscler Thromb Vasc Biol 29:1602-1607
103. Wilner GD, Nossel HL, LeRoy EC (1968) Activation of Hageman factor by collagen. J Clin Invest 47:2608-2615
104. Yeaman MR (2010) Platelets in defense against bacterial pathogens. Cell Mol Life Sci 67:525-544
105. Yuhki K, Kashiwagi H, Kojima F, Kawabe J, Ushikubi F (2010) Roles of prostanoids in the pathogenesis of cardiovascular diseases. Int Angiol 29:19-27
106. Yuhki K, Kojima F, Kashiwagi H, Kawabe J, Fujino T, Narumiya S, Ushikubi F (2011) Roles of prostanoids in the pathogenesis of cardiovascular diseases: novel insights from knockout mouse studies. Pharmacol Ther 129:195-205
107. Zhang H, Lowenberg EC, Crosby JR, MacLeod AR, Zhao C, Gao D, Black C, Revenko AS, Meijers JC, Stroes ES, Levi M, Monia BP (2010) Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood 116:4684-4692
108. Zhu L, Bergmeier W, Wu J, Jiang H, Stalker TJ, Cieslak M, Fan R, Boumsell L, Kumanogoh A, Kikutani H, Tamagnone L, Wagner DD, Milla ME, Brass LF (2007) Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci USA 104:1621-1626